Sponsors of remote monitoring and telehealth devices have a golden opportunity to impact the way the US Centers for Medicare and Medicaid Services sets coding and reimbursements for Food and Drug Administration-approved breakthrough tech devices, CMS officials say.
A proposed rule on reimbursement of FDA breakthrough devices, Medicare Coverage of Innovative Technology, or MCIT, was published in late August. It would not only provide national Medicare coverage for...